Cancer-associated fibroblasts promote colorectal cancer progression by secreting CLEC3B

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29. doi:10.3322/caac.21208.
   PubMed Web of Science ®Google Scholar
• Chu E. Colorectal cancer (CRC) continues to be a major public health problem in the United States and throughout the world. Cancer J. 2010;16:195. doi:10.97/PPO.0b013e3181defd95.
   Google Scholar
• März L, Piso P. Treatment of peritoneal metastases from colorectal cancer. Gastroenterol Rep. 2015;3:298–302. doi:10.1093/gastro/gov044.
   Google Scholar
• Medyouf H. The microenvironment in human myeloid malignancies: emerging concepts and therapeutic implications. Blood. 2017;129:1617–1626. doi:10.1182/blood-2016-11-696070.
   PubMed Web of Science ®Google Scholar
• Chung HW, Lim JB. Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. World J Gastroenterol. 2014;20:1667–1680. doi:10.3748/wjg.v20.i7.1667.
   PubMed Web of Science ®Google Scholar
• Tong H, Ke JQ, Jiang FZ, Wang XJ, Wang FY, Li YR, Lu W, Wan XP. Tumor-associated macrophage-derived CXCL8 could induce ERalpha suppression via HOXB13 in endometrial cancer. Cancer Lett. 2016;376:127–136. doi:10.1016/j.canlet.2016.03.036.
   PubMed Web of Science ®Google Scholar
• Junttila MR, de Sauvage FJ. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013;501:346–354. doi:10.1038/nature12626.
   PubMed Web of Science ®Google Scholar
• Paggetti J, Haderk F, Seiffert M, MJanji B, Distler U, Ammerlaan W, Kim YJ, Adam J, Lichter P, Solary E, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. Blood. 2015;126:1106–1117. doi:10.1182/blood-2014-12-618025.
   PubMed Web of Science ®Google Scholar
• Comito G, Giannoni E, Segura CP, Barcellos-de-Souza P, Raspollini MR, Baroni G, Lanciotti M, Serni S, Chiarugi P. Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression. Oncogene. 2014;33:2423–2431. doi:10.1038/onc.2013.
   PubMed Web of Science ®Google Scholar
• Shangguan L, Ti X, Krause U, Hai B, Zhao Y, Yang Z, Liu F. Inhibition of TGF-beta/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects. Stem Cells. 2012;30:2810–2819. doi:10.1002/stem.
   PubMed Web of Science ®Google Scholar
• Curtis M, Kenny HA, Ashcroft B, Mukherjee A, Johnson A, Zhang Y, Helou Y, Batlle R, Liu X, Gutierrez N, et al. Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis. Cell Metab. 2018. doi:10.1016/j.cmet.2018.08.007.
   Web of Science ®Google Scholar
• Huelsken J, Hanahan D. A subset of cancer-associated fibroblasts determines therapy resistance. Cell. 2018;172(4):643–644. doi:10.1016/j.cell.2018.01.028.
   PubMed Web of Science ®Google Scholar
• Su S, Chen J, Yao H, Liu J, Yu S, Lao L, Wang M, Luo M, Xing Y, Chen F, et al. CD10(+)GPR77(+) cancer-associated fibroblasts promote cancer formation and chemoresistance by sustaining cancer stemness. Cell. 2018;172(4):841–856.e16. doi:10.1016/j.cell.2018.01.009.
   PubMed Web of Science ®Google Scholar
• Zhao XL, Lin Y, Jiang J, Tang Z, Yang S, Lu L, Liang Y, Liu X, Tan J, Hu XG, et al. High-mobility group box 1 released by autophagic cancer-associated fibroblasts maintains the stemness of luminal breast cancer cells. J Pathol. 2017;243(3):376–389. doi:10.1002/path.4958.
   PubMed Web of Science ®Google Scholar
• Huynh PT, Beswick EJ, Coronado YA, Johnson P, O’Connell MR, Watts T, Singh P, Qiu S, Morris K, Powell DW, et al. CD90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer. Int J Cancer. 2016;138:1971–1981. doi:10.1002/ijc.29939.
   PubMed Web of Science ®Google Scholar
• Zhu X, Wang K, Zhang K, Xu F, Yin Y, Zhu L, Zhou F. Galectin-1 knockdown in carcinoma-associated fibroblasts inhibits migration and invasion of human MDA-MB-231 breast cancer cells by modulating MMP-9 expression. Acta Biochim Biophys Sin. 2016;48:462–467. doi:10.1093/abbs/gmw019.
   Google Scholar
• Ellem SJ, Taylor RA, Furic L, Larsson O, Frydenberg M, Pook D, Pedersen J, Cawsey B, Trotta A, Need E, et al. A pro-tumourigenic loop at the human prostate tumour interface orchestrated by oestrogen, CXCL12 and mast cell recruitment. J Pathol. 2014;234:86–98. doi:10.1002/path.4386.
   PubMed Web of Science ®Google Scholar
• Zheng X, Xu M, Yao B, Wang C, Jia Y, Liu Q. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment. Cell Signal. 2016;28:1314–1324. doi:10.1016/j.cellsig.2016.06.009.
   PubMed Web of Science ®Google Scholar
• Shan S, Lv Q, Zhao Y, Liu C, Sun Y, Xi K, Xiao J, Li C. Wnt/beta-catenin pathway is required for epithelial to mesenchymal transition in CXCL12 over expressed breast cancer cells. Int J Clin Exp Pathol. 2015;8:12357–12367.
   PubMed Web of Science ®Google Scholar
• Servais C, Erez N. From sentinel cells to inflammatory culprits: cancer-associated fibroblasts in tumour-related inflammation. J Pathol. 2013;229:198–207. doi:10.1002/path.4103.
   PubMed Web of Science ®Google Scholar
• Du HD, Wu CP, Zhou L, Tian J. Separation and cultivation of laryngeal carcinoma-associated fibroblasts and biological influence on a laryngeal carcinoma cell line. Acta Otolaryngol. 2013;133:755–760. doi:10.3109/00016489.2013.766925.
   PubMed Web of Science ®Google Scholar
• Kikuchi Y, Kashima TG, Nishiyama T, Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo A, et al. Periostin is expressed in pericryptal fibroblasts and cancer-associated fibroblasts in the colon. J Histochem Cytochem. 2008;56:753–764. doi:10.1369/jhc.2008.951061.
   PubMed Web of Science ®Google Scholar
• Chu TY, Yang JT, Huang TH, Liu HW. Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells. Radiat Res. 2014;181:540–547. doi:10.1667/RR13583.
   PubMed Web of Science ®Google Scholar
• Valenti G, Quinn HM, Heynen GJJE, Lan L, Holland JD, Vogel R, Wulf-Goldenberg A, Birchmeier W. Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors. Cancer Res. 2017;77:2134–2147. doi:10.1158/0008-5472.
   PubMedGoogle Scholar
• Bai YP, Shang K, Chen H, Ding F, Wang Z, Liang C, Xu Y, Sun MH, Li YY. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer Sci. 2015;106:1278–1287. doi:10.1111/cas.12745.
   PubMed Web of Science ®Google Scholar
• Ock CY, Nam AR, Bang JH, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ, Oh DY. The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer. Am J Cancer Res. 2015;5:3376–3388.
   PubMed Web of Science ®Google Scholar
• Fuhlendorff J, Clemmensen I, Magnusson S. Primary structure of tetranectin, a plasminogen kringle 4 binding plasma protein: homology with asialoglycoprotein receptors and cartilage proteoglycan core protein. Biochemistry. 1987;26:6757–6764.
   PubMed Web of Science ®Google Scholar
• Caterer NR, Graversen JH, Jacobsen C, Moestrup SK, Sigurskjold BW, Etzerodt M, Thøgersen HC. Specificity determinants in the interaction of apolipoprotein(a) kringles with tetranectin and LDL. Biol Chem. 2002;383:1743–1750. doi:10.1515/BC.2002.195.
   PubMed Web of Science ®Google Scholar
• Verspaget HW, Clemmensen I, Ganesh S, Christensen L, Sier CF, Griffioen G, Lamers CB. Tetranectin expression in human colonic neoplasia. Histopathology. 1994;25:463–467. doi:10.1111/j.1365-2559.1994.tb00008.x.
   PubMed Web of Science ®Google Scholar
• Looi ML, Karsani SA, Rahman MA, Dali AZ, Ali SA, Ngah WZ, Yusof YA. Plasma proteome analysis of cervical intraepithelial neoplasia and cervical squamous cell carcinoma. J Biosci. 2009;34:917–925. doi:10.1007/s12038-009-0106-3.
   PubMed Web of Science ®Google Scholar
• Obrist P, Spizzo G, Ensinger C, Fong D, Brunhuber T, Schäfer G, Varga M, Margreiter R, Amberger A, Gastl G, et al. Aberrant tetranectin expression in human breast carcinomas as a predictor of survival. J Clin Pathol. 2004;57:417–421. doi:10.1136/jcp.2003.010058.
   PubMed Web of Science ®Google Scholar
• De Vries TJ, De Wit PE, Clemmensen I, Verspaget HW, Weidle UH, Bröcker EB, Ruiter DJ, Van Muijen GN. Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions. J Pathol. 1996;179:260–265. doi:10.1002/(SICI)1096-9896(199607)179:3<260::AID-PATH586>3.0.CO;2-T.
   PubMed Web of Science ®Google Scholar
• Arvanitis DL, Kamper EF, Kopeikina L, Stavridou A, Sgantzos MN, Kallioras V, Athanasiou E, Kanavaros P. Tetranectin expression in gastric adenocarcinomas. Histol Histopathol. 2002;17:471–475. doi:10.14670/HH-17.471.
   PubMed Web of Science ®Google Scholar
• Brunner A, Ensinger C, Christiansen M, Heiss S, Verdorfer I, Mikuz G, Tzankov A. Expression and prognostic significance of Tetranectin in invasive and non-invasive bladder cancer. Virchows Arch. 2007;450:659–664. doi:10.1007/s00428-007-0409-4.
   PubMed Web of Science ®Google Scholar
• Henry LR, Lee HO, Lee JS, Klein-Szanto A, Watts P, Ross EA, Chen WT, Cheng JD. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13:1736–1741. doi:10.1158/1078-0432.CCR-06-1746.
   PubMed Web of Science ®Google Scholar